Invivyd (IVVD) Capital Expenditures (QoQ) (2022 - 2025)
Invivyd (IVVD) Capital Expenditures (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - |
| 10 | Invivyd | 102.33 Mn | -124.36 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,930.00% |
| Sep 30, 2025 | -25.00% |
| Jun 30, 2025 | 20.00% |
| Mar 31, 2025 | -100.00% |
| Dec 31, 2024 | 99.66% |
| Sep 30, 2024 | -1,822.37% |
| Jun 30, 2024 | -104.52% |
| Mar 31, 2024 | 14,116.67% |
| Dec 31, 2023 | 88.46% |
| Mar 31, 2023 | -97.90% |
| Dec 31, 2022 | 7,665.08% |
| Sep 30, 2022 | -201.61% |
| Jun 30, 2022 | 102.03% |
| Mar 31, 2022 | -192.81% |